Cencora accounting chief sells 985 shares

Q: What insider transaction did Cencora (COR) disclose in this Form 4?

The filing reports that SVP & Chief Accounting Officer Lazarus Krikorian sold 985 shares of Cencora common stock on September 1, 2026 in a sale characterized as an open market or private transaction.

Q: At what price were the Cencora (COR) shares sold by the officer?

The 985 Cencora shares were sold at a price of $325.97 per share, as reported in the Form 4 for the transaction dated September 1, 2026.

Q: Was the Cencora (COR) insider sale made under a Rule 10b5-1 plan?

Yes. A footnote states the sale was effected pursuant to a Rule 10b5-1 plan adopted by Lazarus Krikorian on June 3, 2026, and the filing affirms Rule 10b5-1 plan status.

Q: Who is the reporting person in this Cencora (COR) Form 4 filing?

The reporting person is Lazarus Krikorian, who serves as Senior Vice President & Chief Accounting Officer of Cencora, Inc., according to the Form 4.

Q: Does this Cencora (COR) Form 4 report any option exercises or derivative transactions?

No. The Form 4 reports only a single sale of 985 common shares and lists no derivative transactions or option exercises in the derivative security section.

Cencora’s chief accounting officer sold a small block of shares under a pre-arranged Rule 10b5-1 trading plan, leaving a reported direct holding of 16,169 shares.

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Cencora, Inc. (COR) reported that SVP & Chief Accounting Officer Lazarus Krikorian sold 985 shares of common stock on September 1, 2026 in an open market or private transaction at $325.97 per share. After this sale, he held 16,169 shares directly. The sale was effected under a Rule 10b5-1 trading plan adopted on June 3, 2026.

Insider Trade Summary 10b5-1

Net Seller: 985 shares

Net Sell 1 txn

Insider Krikorian Lazarus

Role SVP & Chief Accounting Officer

Sold 985 shs ($321K)

Type	Security	Shares	Price	Value
Sale	Common Stock ^F1	985	$325.97	$321K

Holdings After Transaction: Common Stock — 16,169 shares (Direct)

Footnotes (1)

F1. The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on 06/03/2026.

Key Figures

Shares sold: 985 shares Sale price per share: $325.97 per share Shares held after transaction: 16,169 shares +2 more

5 metrics

Shares sold 985 shares Common stock sale on September 1, 2026

Sale price per share $325.97 per share Common stock sale on September 1, 2026

Shares held after transaction 16,169 shares Direct holdings of Lazarus Krikorian after the sale

Net shares sold 985 shares Net selling activity reported in this Form 4

Rule 10b5-1 plan adoption date June 3, 2026 Date the trading plan governing this sale was adopted

Key Terms

Rule 10b5-1 plan, open market or private transaction, beneficial ownership

3 terms

Rule 10b5-1 plan regulatory

"The sale of stock ... was effected pursuant to a Rule 10b5-1 plan"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

open market or private transaction market

"Sale in open market or private transaction"

beneficial ownership financial

"shares following the transaction represent the reporting person's beneficial ownership"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

What insider transaction did Cencora (COR) disclose in this Form 4?

The filing reports that SVP & Chief Accounting Officer Lazarus Krikorian sold 985 shares of Cencora common stock on September 1, 2026 in a sale characterized as an open market or private transaction.

At what price were the Cencora (COR) shares sold by the officer?

The 985 Cencora shares were sold at a price of $325.97 per share, as reported in the Form 4 for the transaction dated September 1, 2026.

How many Cencora (COR) shares does the insider hold after this sale?

After the September 1, 2026 sale, SVP & Chief Accounting Officer Lazarus Krikorian is reported to hold 16,169 shares of Cencora common stock directly.

Was the Cencora (COR) insider sale made under a Rule 10b5-1 plan?

Yes. A footnote states the sale was effected pursuant to a Rule 10b5-1 plan adopted by Lazarus Krikorian on June 3, 2026, and the filing affirms Rule 10b5-1 plan status.

Who is the reporting person in this Cencora (COR) Form 4 filing?

The reporting person is Lazarus Krikorian, who serves as Senior Vice President & Chief Accounting Officer of Cencora, Inc., according to the Form 4.

Does this Cencora (COR) Form 4 report any option exercises or derivative transactions?

No. The Form 4 reports only a single sale of 985 common shares and lists no derivative transactions or option exercises in the derivative security section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 09/02/2026 - 04:01 PM Accepted by SEC EDGAR 09/02/2026 - 04:00 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Krikorian Lazarus

(Last)

(First)

(Middle)

1 WEST FIRST AVENUE

(Street)

CONSHOHOCKEN

PENNSYLVANIA

19428

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cencora, Inc. [ COR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP & Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	09/01/2026		S		985⁽¹⁾	D	$325.97	16,169	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sale of stock reflected in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on 06/03/2026.

Remarks:

	/s/ Elizabeth S. Campbell, attorney-in-fact for Lazarus Krikorian	09/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR